273
Views
15
CrossRef citations to date
0
Altmetric
Research Article

Development and evaluation of rapidly dissolving buccal films of naftopidil: in vitro and in vivo evaluation

, , &
Pages 1695-1706 | Received 12 May 2019, Accepted 10 Aug 2019, Published online: 02 Sep 2019

References

  • Rathi V, Senthil V, Kammili L, et al. A brief review on oral film technology. IJRAP. 2011;2:1138–1147.
  • Lee J, Park J, Robinson J. Bioadhesive-based dosage forms: the next generation. J Pharm Sci. 2000;89:850–866.
  • Veuillez F, Kalia YN, Jacques Y, et al. Factors and strategies for improving buccal absorption of peptides. Eur J Pharm Biopharm. 2001;51:93–109.
  • Joseph R, Vincent K. Lee controlled drug delivery. 2nd ed. New York: Marcel Dekker Inc; 1987. p. 42–43.
  • Borbe H, Metzenauer P, Szelenyi I. 5-HT1A-agonistic properties of naftopidil, a novel antihypertensive drug. Eur J Pharmacol. 1991;205:105–107.
  • Farthing M, Alstead E, Abrams S, et al. Pharmacokinetics of naftopidil, a novel anti-hypertensive drug, in patients with hepatic dysfunction. Postgrad Med J. 1994;70:363–366.
  • Patil R, Nerkar P, Mahajan H, et al. Dissolution rate enhancement and physicochemical characterization of naftopidil in solid dispersions with Β-CD and HP Β-CD. IAJPR. 2015;5:988–994.
  • Khemchand G, Indrajee S. Formulation and evaluation of orally disintegrating tablets of antihypertensive drug naftopidil. AJPRD. 2015;3:1–7.
  • Balata G, Essa E, Shamardl H, et al. Self-emulsifying drug delivery systems as a tool to improve solubility and bioavailability of resveratrol. Drug Des Dev Ther. 2016;10:117–128.
  • Sultan A, El-Gizawy S, Osman M, et al. Colloidal carriers for extended absorption window of furosemide. J Pharm Pharmacol. 2016;68:324–332.
  • Charman W, Stella V. Estimating the maximal potential for intestinal lymphatic transport of lipophilic drug molecules. Int J Pharm. 1986;34:175–178.
  • Dvorackova K, Dolezel K, Maskova K, et al. The effect of acid pH modifiers on the release characteristics of weakly basic drug from hydrophlilic–lipophilic matrices. AAPS PharmSciTech. 2013;14:1341–1348.
  • Castro M, Fonte P, Oliveira A, et al. Optimization of two biopolymer-based oral films for the delivery of bioactive molecules. Mater Sci Eng C. 2017;76:171–180.
  • Adithya B, Krishna U, Vijayalakshmi M, et al. Spectrophotometric estimation of naftopidil in bulk and dosage form. Int Res J Pharm App Sci. 2012;2:26–30.
  • El Maghraby G, Osman M, Abd-Elrahman H, et al. Self emulsifying liquisolid tablets for enhanced oral bioavailability of repaglinide: in vitro and in vivo evaluation. J Appl Pharm Sci. 2014;4:12–21.
  • Shimoda H, Taniguchi K, Nishimura M, et al. Preparation of a fast dissolving oral thin film containing dexamethasone: a possible application to antiemesis during cancer chemotherapy. Eur J Pharm Biopharm. 2009;73:361–365.
  • Kunte S, Tandale P. Fast dissolving strips: a novel approach for the delivery of Verapamil. J Pharm Bioallied Sci. 2010;2:325–328.
  • Brindle L, Krochta J. Physical properties of whey protein-hydroxypropylmethylcellulose blend edible films. J Food Sci. 2008;73:446–454.
  • Khan K. The concept of dissolution efficiency. J Pharm Pharmacol. 1975;27:48–49.
  • El Maghraby G, Abdelzaher M. Formulation and evaluation of simvastatin buccal film. JAPS. 2015;5:70–77.
  • Lin H, Hsu P, Lin S. Theophylline-citric acid co-crystals easily induced by DSC-FTIR microspectroscopy or different storage conditions. Asian J Pharm Sci. 2013;8:18–26.
  • Fukami T, Tahara S, Yasuda C, et al. Structural refinements and thermal properties of L(+)-tartaric, D(–)-tartaric, and monohydrate racemic tartaric acid. IJC. 2016;8:9–21.
  • El Maghraby G, Elsergany R. Fast disintegrating tablets of nisoldipine for intra-oral administration. Pharm Dev Technol. 2014;19:641–650.
  • Hussain M, Kushwaha P, Rahman M, et al. Development and evaluation of fast dissolving film for *Oro-Buccal drug delivery of chlorpromazine. Ijper. 2017;51:s539–s547.
  • Bichara L, Brandán S, Lans H, et al. Vibrational study and force field of the citric acid dimer based on the SQM methodology. Adv Phys Chem. 2011;1:1–10.
  • Sevukarajan M, Sodanapalli R, Thanuja B, et al. Preparation and pharmaceutical characterization of supra molecular complex of isoniazid with L(+) tartaric acid. J Biomed Sci Res. 2011;3:397–402.
  • Chadha R, Saini A, Arora P, et al. Cocrystals of efavirenz with selected conformers: preparation and characterization. Int J Pharm Pharm Sci. 2012;4:244–250.
  • Laitinen R, Löbmann K, Grohganz H, et al. Supersaturating drug delivery systems: the potential of co-amorphous drug formulations. Int J Pharm. 2017;532:1–12.
  • Maher M, Ali M, Salem H, et al. In vitro/in vivo evaluation of an optimized fast dissolving oral film containing olanzapine coamorphous dispersion with selected carboxylic acids. Drug Deliv. 2016;23(8):3088–3100.
  • Ali A, Ali A, Maghrabi I. Clozapine-carboxylic acid plasticized co-amorphous dispersions: preparation, characterization and solution stability evaluation. Acta Pharm. 2015;65:133–146.
  • Hoppu P, Jouppila K, Rantanen J, et al. Characterisation of blends of paracetamol and citric acid. J Pharm Pharmacol. 2007;59:373–381.
  • Venkateswarlu K. Preparation and evaluation of fast dissolving buccal thin films of bufotenin. J ln Silici In Vitro Pharmacol. 2016;103:179–191.
  • Salehi S, Boddohi S. New formulation and approach for mucoadhesive buccal film of rizatriptan benzoate. Prog Biomater. 2017;6:175–187.
  • Himmel H. Naftopidil, a novel antihypertensive drug. Cardiovasc Drug Rev. 1994;12:32–47.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.